429 related articles for article (PubMed ID: 30442330)
1. Regulation of immune responses by E3 ubiquitin ligase Cbl-b.
Tang R; Langdon WY; Zhang J
Cell Immunol; 2019 Jun; 340():103878. PubMed ID: 30442330
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Liu Q; Zhou H; Langdon WY; Zhang J
Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
[TBL] [Abstract][Full Text] [Related]
3. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
[TBL] [Abstract][Full Text] [Related]
4. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
[TBL] [Abstract][Full Text] [Related]
5. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
[TBL] [Abstract][Full Text] [Related]
6. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S; Penninger JM
Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
[TBL] [Abstract][Full Text] [Related]
7. E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.
Jafari D; Mousavi MJ; Keshavarz Shahbaz S; Jafarzadeh L; Tahmasebi S; Spoor J; Esmaeilzadeh A
Clin Exp Immunol; 2021 Apr; 204(1):14-31. PubMed ID: 33306199
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunity.
Zhu LL; Luo TM; Xu X; Guo YH; Zhao XQ; Wang TT; Tang B; Jiang YY; Xu JF; Lin X; Jia XM
J Exp Med; 2016 Jul; 213(8):1555-70. PubMed ID: 27432944
[TBL] [Abstract][Full Text] [Related]
9. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin E3 ligase Cbl-b in T cells tolerance and tumor immunity.
Loeser S; Penninger JM
Cell Cycle; 2007 Oct; 6(20):2478-85. PubMed ID: 17704644
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
[TBL] [Abstract][Full Text] [Related]
12. Complement and platelets: Mutual interference in the immune network.
Speth C; Rambach G; Würzner R; Lass-Flörl C; Kozarcanin H; Hamad OA; Nilsson B; Ekdahl KN
Mol Immunol; 2015 Sep; 67(1):108-18. PubMed ID: 25886718
[TBL] [Abstract][Full Text] [Related]
13. Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro.
Zhou SK; Chen WH; Shi ZD; Wang SP; Li L; Wen XF; Wang YM
J Chin Med Assoc; 2014 Dec; 77(12):630-6. PubMed ID: 25249301
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of targeting IL-17.
Jones SA; Sutton CE; Cua D; Mills KH
Nat Immunol; 2012 Nov; 13(11):1022-5. PubMed ID: 23080193
[TBL] [Abstract][Full Text] [Related]
15. Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Fujiwara M; Anstadt EJ; Khanna KM; Clark RB
Clin Immunol; 2015 May; 158(1):103-13. PubMed ID: 25829233
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.
Balachandran P; Dragone L; Garrity-Ryan L; Lemus A; Weiss A; Engel J
J Clin Invest; 2007 Feb; 117(2):419-27. PubMed ID: 17235393
[TBL] [Abstract][Full Text] [Related]
17. Cbl and Cbl-b in T-cell regulation.
Liu YC; Gu H
Trends Immunol; 2002 Mar; 23(3):140-3. PubMed ID: 11864842
[TBL] [Abstract][Full Text] [Related]
18. Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection.
Ou R; Zhang M; Huang L; Moskophidis D
J Virol; 2008 Apr; 82(7):3353-68. PubMed ID: 18199651
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
20. NF-κB downregulates Cbl-b through binding and suppressing Cbl-b promoter in T cell activation.
Liu Y; Li Y; Zhang L; Li M; Li C; Xue C; Huang X; Zhou P
J Immunol; 2015 Apr; 194(8):3778-83. PubMed ID: 25762784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]